These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21426160)

  • 21. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
    Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors.
    Barreca ML; Iraci N; De Luca L; Chimirri A
    ChemMedChem; 2009 Sep; 4(9):1446-56. PubMed ID: 19544345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
    Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
    J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational modeling methods for QSAR studies on HIV-1 integrase inhibitors (2005-2010).
    Ko GM; Reddy AS; Garg R; Kumar S; Hadaegh AR
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):255-70. PubMed ID: 22242796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds].
    Yu SH; Tan YM; Zhao GS
    Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
    Bhatt H; Patel P; Pannecouque C
    Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors.
    Patel M; Cianci C; Allard CW; Parker DD; Simmermacher J; Jenkins S; Mcauliffe B; Minassian B; Discotto L; Krystal M; Meanwell NA; Naidu BN
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127516. PubMed ID: 32860982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and function of HIV-1 integrase.
    Chiu TK; Davies DR
    Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial.
    Johnson AA; Marchand C; Pommier Y
    Curr Top Med Chem; 2004; 4(10):1059-77. PubMed ID: 15193139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation.
    De Luca L; De Grazia S; Ferro S; Gitto R; Christ F; Debyser Z; Chimirri A
    Eur J Med Chem; 2011 Feb; 46(2):756-64. PubMed ID: 21227550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H.
    Yang F; Yang J; Zhang Z; Tu G; Yao X; Xue W; Zhu F
    Curr Med Chem; 2022; 29(10):1664-1676. PubMed ID: 34238145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR studies of HIV-1 integrase inhibition.
    Yuan H; Parrill AL
    Bioorg Med Chem; 2002 Dec; 10(12):4169-83. PubMed ID: 12413870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
    Dessalew N
    Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 integrase inhibition: binding sites, structure activity relationships and future perspectives.
    Parrill AL
    Curr Med Chem; 2003 Sep; 10(18):1811-24. PubMed ID: 12871106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
    Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
    J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.